Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/31/25 18:53 | 1/31/25 | ETST | Health | Drug | Pharmaceutical Preparations | Sanchez Yovan Arturo | FL | D | 3 | P | 37 | 0.1434 | 0 | 256 | 20 | 1,506 | D | |||||||||||||||
1/28/25 13:03 | 1/28/25 | ETST | Health | Drug | Pharmaceutical Preparations | Flores Ernesto L | FL | DO | CFO | 1 | P | 10 | 0.2300 | 0 | 43 | 84 | 95 | D | ||||||||||||||
1/27/25 06:13 | 1/24/25 | ETST | Health | Drug | Pharmaceutical Preparations | Tabraue Mario Guillermo | FL | DO | COO | 1 | P | 5 | 0.2300 | 0 | 20 | 0 | 12,382 | D | ||||||||||||||
1/16/25 18:34 | 12/27/24 | ETST | Health | Drug | Pharmaceutical Preparations | Saumat Giorgio R. | FL | DOT | CEO | 2 | P.m | 171 | 0.1918 | 0 | 892 | 1 | 122,680 | D | ||||||||||||||
1/10/25 18:25 | 1/8/25 | ETST | Health | Drug | Pharmaceutical Preparations | Cazeau Jeff P. H. | FL | H | Independ | 5 | P | 49 | 0.1424 | 0 | 347 | 319 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |